KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AbbVie (ABBV) Interest & Investment Income (2016 - 2026)

AbbVie has reported Interest & Investment Income over the past 14 years, most recently at -$655.0 million for Q4 2025.

  • Quarterly Interest & Investment Income fell 7.38% to -$655.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.6 billion through Dec 2025, down 21.62% year-over-year, with the annual reading at -$2.6 billion for FY2025, 21.62% down from the prior year.
  • Interest & Investment Income was -$655.0 million for Q4 2025 at AbbVie, up from -$667.0 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at -$378.0 million in Q4 2023 and troughed at -$678.0 million in Q2 2025.
  • The 5-year median for Interest & Investment Income is -$555.0 million (2021), against an average of -$544.9 million.
  • Year-over-year, Interest & Investment Income grew 20.59% in 2023 and then tumbled 61.38% in 2024.
  • A 5-year view of Interest & Investment Income shows it stood at -$571.0 million in 2021, then rose by 16.64% to -$476.0 million in 2022, then grew by 20.59% to -$378.0 million in 2023, then tumbled by 61.38% to -$610.0 million in 2024, then decreased by 7.38% to -$655.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Interest & Investment Income are -$655.0 million (Q4 2025), -$667.0 million (Q3 2025), and -$678.0 million (Q2 2025).